Analysis of Inventory
Paying user area
Try for free
Abbott Laboratories pages available for free this week:
- Common-Size Balance Sheet: Liabilities and Stockholders’ Equity
- Analysis of Profitability Ratios
- Analysis of Geographic Areas
- Common Stock Valuation Ratios
- Enterprise Value to FCFF (EV/FCFF)
- Return on Equity (ROE) since 2005
- Return on Assets (ROA) since 2005
- Price to Earnings (P/E) since 2005
- Price to Operating Profit (P/OP) since 2005
- Analysis of Debt
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to Abbott Laboratories for $24.99.
This is a one-time payment. There is no automatic renewal.
We accept:
Inventory Disclosure
Abbott Laboratories, balance sheet: inventory
US$ in millions
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Finished products | |||||||||||
| Work in process | |||||||||||
| Materials | |||||||||||
| Inventories |
Based on: 10-K (reporting date: 2024-12-31), 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31).
The financial data reveals a general upward trend in inventory components over the five-year period from 2020 to 2024, with varying growth rates and some fluctuation in the most recent year.
- Finished Products
- The finished products inventory experienced growth from 3030 million US dollars in 2020 to a peak of 3946 million US dollars in 2023. However, in 2024, a slight decline to 3700 million US dollars is observed, indicating a potential reduction in finished goods held or improved sales performance that year.
- Work in Process
- Work in process inventory remained relatively stable during the early years, slightly declining from 712 million US dollars in 2020 to 680 million US dollars in 2022. Thereafter, it increased steadily to 807 million in 2023 and further to 840 million in 2024, reflecting a possible intensification of production activities or extended production cycles in the latter years.
- Materials
- Material inventories showed consistent growth from 1270 million US dollars in 2020 to a high of 1817 million in 2023. Similar to finished products, a decrease to 1654 million US dollars is seen in 2024, which could imply better inventory management, supply chain adjustments, or higher utilization of raw materials during that year.
- Inventories (Total)
- Total inventories, combining finished products, work in process, and materials, increased steadily from 5012 million US dollars in 2020 to a peak of 6570 million in 2023. In 2024, a reduction to 6194 million US dollars occurred, consistent with declines noted in finished products and materials inventories, suggesting overall inventory optimization or demand shifts in the latest year.
Overall, the trend demonstrates growth in inventory components over the majority of the period, with a slight pullback in 2024. This pattern may be reflective of operational scaling followed by an adjustment phase aimed at balancing inventory levels with demand and production efficiency.